🌙 NT1 care is entering a new era. Compare orexin receptor agonists with wake-promoting agents, unpack the 🧬 latest clinical data, and strengthen your ability to recognize and diagnose narcolepsy type 1. 💡 Wake up to what’s next—reserve your spot! mdsc.pe/45QnuiD
#NT1
😴➡️⚡ What’s next in narcolepsy type 1? Explore how orexin receptor agonists differ from traditional wake-promoting agents, review the latest clinical data 🔬 & sharpen your approach to NT1 diagnosis. 🧠 Stay ahead of emerging science—register today! mdsc.pe/45QnuiD
#NT1
🦋 Earlier recognition can reshape the fibromyalgia journey. Take a closer look at symptom burden, strengthen timely diagnosis & explore therapies tailored to the symptoms that matter most to each patient. 💜 Elevate your fibromyalgia care—save your spothttps://mdsc.pe/4zTu31q #AAFPFMX
🔬 Could factor XIa inhibitors change the secondary stroke prevention landscape? Examine the latest clinical evidence, who’s being studied in phase 3 trials 🧠 & what emerging data reveal about benefits and risks. 🛡️ Bring tomorrow’s evidence into focus—save your spot! 👉 mdsc.pe/461BplZ
🔎 Is your patient with CIDP responding optimally to treatment? Strengthen your approach to identifying treatment-refractory disease and adjusting immunoglobulin therapy. 📈 Learn how clinical metrics can help track treatment response in routine practice.
💡 Start learning: mdsc.pe/4rOS7ix
🦠 When antibiotics aren’t the answer, the right conversation matters. Explore rapid multiplex testing, 🧫 diagnostic stewardship & smarter workflows that support appropriate antibiotic use. 💬 Strengthen your AMS strategy—register today! mdsc.pe/4qNRYew #AAFPFMX
😴 OSA doesn’t always look like the “typical” patient. Learn to recognize overlooked presentations in primary care, explore the 🩺 clinical benefits of CPAP & tackle barriers that can limit its use. 🌙 Strengthen your OSA strategy—register today! mdsc.pe/4ynljzf #AAFPFMX
🧠 Managing CIDP requires knowing when—and how—to adjust treatment. Explore strategies for tapering, switching, or discontinuing immunoglobulin therapy and learn to identify treatment-refractory CIDP. 📊 Apply clinical metrics to better monitor response in practice.
👉 Explore the activity: mdsc.pe/4rOS7ix
🧠 Earlier intervention may make a difference in seizure rescue. ⏱️ Explore the REST paradigm, identify appropriate patients, and 💡 build confidence educating patients & caregivers on when to intervene.
🎟️ Register today! mdsc.pe/4B7UiCb
🔬 Beyond seizure control: What are patients with focal epilepsy really experiencing while taking ASMs? 🧠 Explore the clinical data, emerging therapies & tools that can help capture outcomes that matter. 💡 Join us and discover what’s ahead! ⚡
mdsc.pe/4rxmycI
🌊 Stroke prevention is entering new territory. Discover why factor XI/XIa is emerging as a therapeutic target, 🧳 unpack the latest trial data & explore which patients may benefit from factor XIa inhibition. 🔬 Get ahead of what’s next—claim your spot today! mdsc.pe/4zL8kc1
😴➡️⚡ What’s next in narcolepsy type 1? Explore how orexin receptor agonists differ from traditional wake-promoting agents, review the latest clinical data 🔬 & sharpen your approach to NT1 diagnosis. 🧠 Stay ahead of emerging science—register today! mdsc.pe/45QnuiD
#NT1
🦠 When antibiotics aren’t the answer, the right conversation matters. Explore rapid multiplex testing, 🧫 diagnostic stewardship & smarter workflows that support appropriate antibiotic use. 💬 Strengthen your AMS strategy—register today! mdsc.pe/4qNRYew #AAFPFMX
🌙 NT1 care is entering a new era. Compare orexin receptor agonists with wake-promoting agents, unpack the 🧬 latest clinical data, and strengthen your ability to recognize and diagnose narcolepsy type 1. 💡 Wake up to what’s next—reserve your spot! mdsc.pe/45QnuiD
#NT1
Why do patients with generalized myasthenia gravis often struggle despite "looking fine" to others?
Dr. Carissa Gable, Dr. Carolina Barnett-Tapia, and patient advocate Ms. Tao Nguyen discuss the hidden burden and emotional weight of gMG.
Watch the full discussion ➡️ mdsc.pe/4i2RSfb
#MedEd #Neurology #CME
🎯 Stay ahead of advances in IDH-mutant glioma! Explore the latest data on emerging targeted therapies, strategies for treatment following surgical resection, and approaches to optimizing long-term care. 📈 Build confidence navigating complex decisions. 🧩 mdsc.pe/4yXp7Y3
Enhance your ability to navigate acute seizure termination with expert perspectives, the latest evidence, and real-world strategies for treatment selection. Apply key clinical insights that help optimize care during critical moments.
mdsc.pe/3V9Hv1h
🔬 Could factor XIa inhibitors change the secondary stroke prevention landscape? Examine the latest clinical evidence, who’s being studied in phase 3 trials 🧠 & what emerging data reveal about benefits and risks. 🛡️ Bring tomorrow’s evidence into focus—save your spot! 👉 mdsc.pe/461BplZ
⚡ Stay ahead in Dravet syndrome care. Discover the latest data on disease-modifying therapies, strengthen your diagnostic confidence, personalize treatment strategies, and build effective multidisciplinary care plans. 💜 Register now! mdsc.pe/4xalNrB
💤 Could OSA be hiding in plain sight? Sharpen your ability to identify non-traditional patients, 🔎 examine the benefits of CPAP, and gain practical strategies to overcome treatment barriers in primary care.⚡Make better sleep part of better care—save your spot! mdsc.pe/4ynljzf #AAFPFMX



















